BlackRock
IMCR icon

BlackRock’s Immunocore IMCR Stock Holding History

BlackRock’s Portfolio IMCR Stock Details IMCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$31.9M Buy
1,004,598
+348,289
+53% +$10.3M ﹤0.01% 2957
2026
Q1 		$19.8M Buy
656,309
+327,210
+99% +$10.6M ﹤0.01% 3087
2025
Q4 		$11.4M Buy
329,099
+83,894
+34% +$2.96M ﹤0.01% 3397
2025
Q3 		$8.91M Buy
245,205
+23,826
+11% +$809K ﹤0.01% 3509
2025
Q2 		$6.95M Sell
221,379
-4,166
-2% -$129K ﹤0.01% 3599
2025
Q1 		$6.69M Sell
225,545
-47,235
-17% -$1.42M ﹤0.01% 3515
2024
Q4 		$8.05M Sell
272,780
-600,831
-69% -$19M ﹤0.01% 3533
2024
Q3 		$27.2M Buy
873,611
+1,818
+0.2% +$66.1K ﹤0.01% 2836
2024
Q2 		$29.5M Buy
871,793
+4,436
+0.5% +$226K ﹤0.01% 2748
2024
Q1 		$56.4M Buy
867,357
+88,326
+11% +$6.06M ﹤0.01% 2369
2023
Q4 		$53.2M Buy
779,031
+19,198
+3% +$998K ﹤0.01% 2435
2023
Q3 		$39.4M Sell
759,833
-32,251
-4% -$1.91M ﹤0.01% 2539
2023
Q2 		$47.5M Buy
792,084
+14,158
+2% +$808K ﹤0.01% 2518
2023
Q1 		$38.5M Sell
777,926
-11,069
-1% -$622K ﹤0.01% 2623
2022
Q4 		$45M Buy
788,995
+289,563
+58% +$16.3M ﹤0.01% 2544
2022
Q3 		$23.4M Buy
499,432
+3,250
+0.7% +$155K ﹤0.01% 2948
2022
Q2 		$18.5M Hold
496,182
– – ﹤0.01% 3128
2022
Q1 		$14.8M Hold
496,182
– – ﹤0.01% 3362
2021
Q4 		$17M Sell
496,182
-331,422
-40% -$12M ﹤0.01% 3374
2021
Q3 		$30.7M Sell
827,604
-252,322
-23% -$8.52M ﹤0.01% 3000
2021
Q2 		$42.2M Sell
1,079,926
-199
-0% -$7.68K ﹤0.01% 2810
2021
Q1 		$46M Buy
+1,080,125
New +$48.1M ﹤0.01% 2672

Other funds holding IMCR

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

BlackRock's IMCR Position: Q2 2026 in Review

BlackRock increased its Immunocore (IMCR) stake by 53% in Q2 2026, buying an estimated $10.3M and bringing the position to 1,004,598 shares worth $31.9M. The position accounts for ﹤0.01% of the portfolio, ranked #2957.

BlackRock first reported a position in IMCR in Q1 2021 and has held it in 22 quarters since. The position peaked at $56.4M in Q1 2024. 136 funds tracked by Wall St. Rank hold IMCR as of Q2 2026.

  • BlackRock held 1,004,598 shares of Immunocore worth $31.9M as of Q2 2026.
  • BlackRock bought 348,289 Immunocore shares in Q2 2026, an estimated $10.3M.
  • Immunocore made up ﹤0.01% of BlackRock's portfolio in Q2 2026, its #2957 holding.
  • BlackRock first reported a position in Immunocore in Q1 2021 and has held it in 22 quarters since.
  • BlackRock's Immunocore position peaked at $56.4M in Q1 2024.
  • 136 funds tracked by Wall St. Rank held Immunocore as of Q2 2026.

Based on BlackRock's 13F filing for Q2 2026, filed 7 Aug 2026.